Le Lézard
Classified in: Health, Science and technology, Business
Subjects: LIC, FVT

ODAIA Partners with Veeva to Accelerate Adoption of AI in Life Sciences


ODAIA is first company to join Veeva AI Partner Program and provide industry's first GenAI solution for Veeva Vault CRM

Company to deliver LLM-driven, real-time, predictive insights in Veeva Vault CRM for sales to enhance call planning, pre-call insights, and HCP engagement

BOSTON, May 7, 2024 /PRNewswire/ -- Veeva Commercial Summit -- ODAIA today announced it is expanding its product partnership with Veeva Systems, joining the Veeva AI Partner Program to advance the use of Generative AI (GenAI) in life sciences. As the first product partner in the program, ODAIA will deliver an integrated GenAI solution that provides real-time, predictive insights right in Veeva Vault CRM. Sales teams will be able to enhance call planning and pre-call planning to drive more targeted, relevant, timely, and personalized engagement with healthcare professionals (HCPs).

The ODAIA platform, MAPTUAL, is the first and only Customer Science cloud for pharma that combines data science and behavioral science with AI and machine learning to gain a deep understanding of HCPs and their patients' journeys. MAPTUAL analyzes vast amounts of data to predict future HCP behavioral trends and prescribing patterns in real time. Innovative companies, including three of the top 15 largest biopharma organizations, use ODAIA to improve HCP targeting and engagement and get treatments to patients faster.

"GenAI is a new technology that is rapidly evolving. Veeva's strategy is to enable our customers and partners to develop AI solutions that work well with any Veeva Vault application," said Paul Shawah, executive vice president of commercial strategy at Veeva. "Giving sales reps AI-driven, real-time insights can simplify and enhance pre-call planning, which can drive more valued engagement with HCPs."

Typical GenAI copilot approaches depend on users writing multiple prompts to generate the desired answers and outputs, but results are often inconsistent. The ODAIA GenAI solution features a guided-large language model (LLM) designed to automatically ingest and process data. Now companies can surface and deliver summarized insights for sales reps with greater accuracy the first time ? all without user-generated prompts.

ODAIA tells sales reps everything they need to know before visiting an HCP, from prescribing behavior and competitive insights to patient triggers and personal and non-personal promotional activities. Using the Vault Direct Data API to access Vault CRM data, the ODAIA LLM engine will provide tailored insights instantly in Vault CRM, giving sales reps details directly within their current workflow as they prepare for their week, day, or individual call.

"Sales leaders want their teams focused on engaging HCPs, not prompt engineering and figuring out the right questions to ask a copilot tool. Our LLM engine automatically delivers insights users wouldn't even think to ask about," said Philip Poulidis, CEO at ODAIA. "With Veeva's high-speed Direct Data API, we can provide sales reps with clear and actionable real-time details in Veeva Vault CRM to enhance the entire HCP engagement process, making it more timely, relevant, and effective."

The ODAIA GenAI solution is currently in early adoption phase with select customers. General availability within Vault CRM is planned for Q3 2024.

To learn more, attend ODAIA's Innovation Theater Session at Veeva Commercial Summit on Wednesday, May 8, from 12:30 - 12:45 PM in the CRM Suite Theater. CEO Philip Poulidis will demonstrate the use of advanced AI capabilities to automate data analysis and deliver personalized GenAI-powered insights in Vault CRM. To schedule a meeting with the ODAIA team at the event, visit https://www.odaia.ai/event/veeva-commercial-summit-2024.

About ODAIA
ODAIA is the leading AI company helping life sciences companies innovate their commercial strategies using Customer Science. The company's cloud solution, MAPTUAL, integrates data science, behavioral science, and AI to gain a deep understanding of healthcare professionals (HCPs) and their patient decisions across the entire customer journey. To learn more about ODAIA, visit our website or follow us on LinkedIn.

SOURCE ODAIA


These press releases may also interest you

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...

at 06:13
eWTP Arabia Capital Technology Fund I ("Techology Fund I"), managed by eWTP Arabia Capital ("eWTPA"), one of the leading private equity firms in the Middle East, was listed in the Preqin League Tables as the the fifth top-performing VC funds in the...

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...



News published on and distributed by: